Lung Tissue Preparation
Lung Tissue Preparation - Related Videos
08:01
Engineered Lung Tissues Prepared from Decellularized Lung Slices
0 Views •
Cited by 7 •
2022
This protocol describes a method to generate reproducible, small-scale engineered lung tissues, by repopulating decellularized precision-cut lung slices with alveolar epithelial type 2 cells, fibroblasts, and endothelial cells.
03:48
Mouse Lung Preparation for Flow Cytometry: Generating Cell Suspension from Lung Tissue for Flow Cytometric Analysis
0 Views •
2023
This video describes the preparation of mouse lung cell suspension for flow cytometric analysis to study PD-L1 expression of lung adenocarcinoma cells.
07:03
Standardized Preparation of Single-Cell Suspensions from Mouse Lung Tissue using the gentleMACS Dissociator
0 Views •
Cited by 45 •
2009
Dissociating cells from specific tissue types requires specific parameters for tissue agitation to obtain a high volume of viable, culturable cells. The Miltenyi gentleMACS dissociator optimizes this task with a simple, practical protocol. In this publication the use of this apparatus on lung tissue is explained.
05:55
Whole Lung Agarose Inflation: A Method of Preparing Lungs for Ex vivo Live Imaging
0 Views •
2023
This video describes a method of preparing lungs for ex vivo live imaging to study interactions between cancer cells and stromal cells, using agarose for inflation. In the sample protocol, agarose inflation procedure is described before observing live cellular interactions.
04:26
Agarose-Based Preparation of Human Precision-Cut Lung Slices
0 Views •
2025
In this video, we describe a procedure to inflate isolated human lungs with agarose and prepare human precision-cut lung slices. The prepared ex vivo lung slices can be used for further immunologic experiments.
FAQs
Fixation preserves cellular architecture and helps limit tissue degradation before microscopic evaluation. This is especially important when researchers need to examine tumor margins, stromal interactions, or cellular morphology, because deterioration can obscure relationships between malignant cells and surrounding tissue. Consistent preservation therefore supports more reliable interpretation of structural features in lung cancer specimens.
Careful sampling determines which biological features remain available for analysis. Preserving tumor margins and adjacent stromal interactions can help researchers evaluate how cancer relates to surrounding tissue rather than viewing tumor cells in isolation. Sampling quality consequently affects microscopic assessment and may influence the tissue available for biomarker detection, genomic studies, or progression analysis.
Processing artifacts can alter or obscure cellular morphology and tissue relationships, making microscopic findings harder to interpret. They may also compromise the quality of material selected for downstream assays. Limiting degradation and preparation-related distortion is therefore essential when comparing tumor features, assessing treatment response, or connecting visible structural changes with lung cancer biology.
The workflow begins with careful specimen sampling, followed by fixation to preserve the tissue. The specimen is then embedded in a supportive medium and cut into thin sections. Those sections can undergo staining for microscopic evaluation or be directed to downstream assays, allowing one prepared specimen to support structural and molecular investigations.
Prepared lung specimens can support histopathology, biomarker detection, and genomic studies. They also allow researchers to evaluate tumor progression and treatment response by examining tissue structure alongside molecular findings. Using the same preparation process across these applications helps connect visible changes in tumor and stromal features with biological measurements relevant to cancer research.
The specimen provides a basis for relating structural findings to biological behavior. Researchers can examine cellular morphology, tumor margins, and interactions with the stroma, then connect those observations with biomarker or genomic results. This integrated view supports investigation of tumor progression and treatment response, rather than relying on a single type of cancer-related measurement.